Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin

NCT01340235 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT01340235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01340235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2011
Completion date
June 30, 2012
Enrollment
8 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa